• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nitrates and nitrites in the treatment of ischemic cardiac disease.硝酸盐和亚硝酸盐在缺血性心脏病治疗中的应用。
Cardiol Rev. 2010 Jul-Aug;18(4):190-7. doi: 10.1097/CRD.0b013e3181c8e14a.
2
Inorganic nitrite and nitrate in cardiovascular therapy: A better alternative to organic nitrates as nitric oxide donors?无机亚硝酸盐和硝酸盐在心血管治疗中的作用:作为一氧化氮供体,优于有机硝酸盐?
Vascul Pharmacol. 2018 Mar;102:1-10. doi: 10.1016/j.vph.2017.11.003. Epub 2017 Nov 22.
3
'The heart less bounding': treating angina pectoris.“心跳不再剧烈”:治疗心绞痛
J R Coll Physicians Edinb. 2006 Jun;36(2):185-9.
4
Vascular and hemodynamic differences between organic nitrates and nitrites.有机硝酸盐和亚硝酸盐之间的血管及血流动力学差异。
J Pharmacol Exp Ther. 1997 Jan;280(1):326-31.
5
[Therapy of angina pectoris. II. Evaluation of antianginous drugs. Nitrites and nitrates].[心绞痛的治疗。II. 抗心绞痛药物的评估。亚硝酸盐和硝酸盐]
Clin Ter. 1974 Jan 31;68(2):105-36.
6
Therapeutic uses of inorganic nitrite and nitrate: from the past to the future.无机亚硝酸盐和硝酸盐的治疗用途:从过去到未来。
Circulation. 2008 Apr 22;117(16):2151-9. doi: 10.1161/CIRCULATIONAHA.107.753814.
7
Nitroglycerine and sodium trioxodinitrate: from the discovery to the preconditioning effect.硝化甘油和三氧化二硝酰钠:从发现到预处理效应。
J Cardiovasc Med (Hagerstown). 2013 Oct;14(10):698-704. doi: 10.2459/JCM.0b013e3283621ac6.
8
A short history of nitroglycerine and nitric oxide in pharmacology and physiology.药理学与生理学中硝酸甘油和一氧化氮的简史。
Clin Exp Pharmacol Physiol. 2000 Apr;27(4):313-9. doi: 10.1046/j.1440-1681.2000.03240.x.
9
Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase.亚硝酸盐衍生的一氧化氮在体内保护大鼠肾脏免受缺血/再灌注损伤:黄嘌呤氧化还原酶的作用
J Am Soc Nephrol. 2007 Feb;18(2):570-80. doi: 10.1681/ASN.2006050450. Epub 2007 Jan 3.
10
Pharmacology and therapeutic role of inorganic nitrite and nitrate in vasodilatation.无机亚硝酸盐和硝酸盐在血管舒张中的药理学和治疗作用。
Pharmacol Ther. 2014 Dec;144(3):303-20. doi: 10.1016/j.pharmthera.2014.06.009. Epub 2014 Jun 30.

引用本文的文献

1
Hydrogel-Based Nitric Oxide Delivery Systems for Enhanced Wound Healing.用于促进伤口愈合的水凝胶基一氧化氮递送系统
Gels. 2025 Aug 8;11(8):621. doi: 10.3390/gels11080621.
2
Mitochondrial homeostasis restoring peptide-drug conjugates with ROS-responsive NO releasing ability for targeted therapy of myocardial infarction.具有ROS响应性NO释放能力的线粒体稳态恢复肽-药物偶联物用于心肌梗死的靶向治疗
J Nanobiotechnology. 2025 Jul 8;23(1):496. doi: 10.1186/s12951-025-03578-6.
3
NitrOFF: An engineered fluorescent biosensor to illuminate nitrate transport in living cells.NitrOFF:一种用于揭示活细胞中硝酸盐转运的工程化荧光生物传感器。
bioRxiv. 2025 Mar 23:2025.03.22.644677. doi: 10.1101/2025.03.22.644677.
4
Inhaled nitric oxide testing in predicting prognosis in pulmonary hypertension due to left-sided heart diseases.吸入一氧化氮测试在预测左心疾病所致肺动脉高压的预后中的应用。
ESC Heart Fail. 2023 Dec;10(6):3592-3603. doi: 10.1002/ehf2.14515. Epub 2023 Sep 29.
5
Investigation of the Inhibition Mechanism of Xanthine Oxidoreductase by Oxipurinol: A Computational Study.黄嘌呤氧化酶抑制剂别嘌呤醇抑制机制的研究:计算研究。
J Chem Inf Model. 2023 Jul 10;63(13):4190-4206. doi: 10.1021/acs.jcim.3c00624. Epub 2023 Jun 15.
6
The Clinical Assessment and Treatment of Inhalant Abuse.《吸入剂滥用的临床评估与治疗》。
Perm J. 2023 Jun 15;27(2):99-109. doi: 10.7812/TPP/22.164. Epub 2023 Apr 20.
7
Updates on Pharmacologic Management of Microvascular Angina.微血管性心绞痛的药物治疗进展。
Cardiovasc Ther. 2022 Oct 25;2022:6080258. doi: 10.1155/2022/6080258. eCollection 2022.
8
Large-scale production of CdO/Cd(OH) nanocomposites for non-enzyme sensing and supercapacitor applications.用于非酶传感和超级电容器应用的CdO/Cd(OH)纳米复合材料的大规模生产。
RSC Adv. 2018 Jan 3;8(2):921-930. doi: 10.1039/c7ra09457d. eCollection 2018 Jan 2.
9
Mechanistic Insights into Inorganic Nitrite-Mediated Vasodilation of Isolated Aortic Rings under Oxidative/Hypertensive Conditions and S-Nitros(yl)ation of Proteins in Germ-Free Mice.无机亚硝酸盐在氧化/高血压条件下介导离体主动脉环血管舒张以及无菌小鼠体内蛋白质S-亚硝基化的机制研究
Biomedicines. 2022 Mar 21;10(3):730. doi: 10.3390/biomedicines10030730.
10
Pharmacologic Management of Coronary Artery Ectasia.冠状动脉扩张症的药物治疗
Cureus. 2021 Sep 8;13(9):e17832. doi: 10.7759/cureus.17832. eCollection 2021 Sep.

本文引用的文献

1
The Bradshaw Lecture on some New Vaso-Dilators: Delivered before the Royal College of Physicians of London.关于一些新型血管扩张剂的布拉德肖讲座:在伦敦皇家内科医师学院发表。
Br Med J. 1895 Nov 16;2(1820):1213-8. doi: 10.1136/bmj.2.1820.1213.
2
Vascular responses to nitrite are mediated by xanthine oxidoreductase and mitochondrial aldehyde dehydrogenase in the rat.血管对亚硝酸盐的反应是由大鼠中的黄嘌呤氧化还原酶和线粒体乙醛脱氢酶介导的。
Can J Physiol Pharmacol. 2009 Dec;87(12):1095-101. doi: 10.1139/Y09-101.
3
Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases.一氧化氮与血管疾病发生发展中的致病机制。
Arch Pharm Res. 2009 Aug;32(8):1103-8. doi: 10.1007/s12272-009-1801-1. Epub 2009 Aug 29.
4
Food sources of nitrates and nitrites: the physiologic context for potential health benefits.硝酸盐和亚硝酸盐的食物来源:潜在健康益处的生理背景
Am J Clin Nutr. 2009 Jul;90(1):1-10. doi: 10.3945/ajcn.2008.27131. Epub 2009 May 13.
5
Pulmonary vasodilator responses to sodium nitrite are mediated by an allopurinol-sensitive mechanism in the rat.大鼠对亚硝酸钠的肺血管舒张反应是由一种对别嘌呤醇敏感的机制介导的。
Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H524-33. doi: 10.1152/ajpheart.00543.2008. Epub 2008 Dec 12.
6
The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles.硝酸甘油生物活化与硝酸盐耐受性之谜:新进展、观点与问题
Br J Pharmacol. 2008 Sep;155(2):170-84. doi: 10.1038/bjp.2008.263. Epub 2008 Jun 23.
7
Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases.纯化的线粒体和胞质醛脱氢酶对硝酸甘油的生物活化作用。
J Biol Chem. 2008 Jun 27;283(26):17873-80. doi: 10.1074/jbc.M801182200. Epub 2008 May 1.
8
Therapeutic uses of inorganic nitrite and nitrate: from the past to the future.无机亚硝酸盐和硝酸盐的治疗用途:从过去到未来。
Circulation. 2008 Apr 22;117(16):2151-9. doi: 10.1161/CIRCULATIONAHA.107.753814.
9
Nitric oxide production from nitrite occurs primarily in tissues not in the blood: critical role of xanthine oxidase and aldehyde oxidase.亚硝酸盐产生一氧化氮主要发生在组织而非血液中:黄嘌呤氧化酶和醛氧化酶的关键作用。
J Biol Chem. 2008 Jun 27;283(26):17855-63. doi: 10.1074/jbc.M801785200. Epub 2008 Apr 18.
10
Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite.膳食硝酸盐通过生物转化为亚硝酸盐的急性降压、血管保护和抗血小板特性。
Hypertension. 2008 Mar;51(3):784-90. doi: 10.1161/HYPERTENSIONAHA.107.103523. Epub 2008 Feb 4.

硝酸盐和亚硝酸盐在缺血性心脏病治疗中的应用。

Nitrates and nitrites in the treatment of ischemic cardiac disease.

机构信息

Department of Pharmacology, Tulane University Medical Center, New Orleans, LA 70112-2699, USA.

出版信息

Cardiol Rev. 2010 Jul-Aug;18(4):190-7. doi: 10.1097/CRD.0b013e3181c8e14a.

DOI:10.1097/CRD.0b013e3181c8e14a
PMID:20539102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2885014/
Abstract

The organic nitrite, amyl of nitrite, was initially used as a therapeutic agent in the treatment of angina pectoris, but was replaced over a decade later by the organic nitrate, nitroglycerin (NTG), due to the ease of administration and longer duration of action. The administration of organic nitrate esters, such as NTG, continues to be used in the treatment of angina pectoris and heart failure since the birth of modern pharmacology. Their clinical effectiveness is due to vasodilator activity in large veins and arteries through an as yet unidentified method of delivering nitric oxide (NO), or a NO-like compound. The major drawback is the development of tolerance with NTG, and the duration and route of administration with amyl of nitrite. Although the nitrites are no longer used in the treatment of hypertension or ischemic heart disease, the nitrite anion has recently been discovered to possess novel pharmacologic actions, such as modulating hypoxic vasodilation, and providing cytoprotection in ischemia-reperfusion injury. Although the actions of these 2 similar chemical classes (nitrites and organic nitrates) have often been considered to be alike, we still do not understand their mechanism of action. Finally, the nitrite anion, either from sodium nitrite or an intermediate NTG form, may act as a storage form for NO and provide support for investigating the use of these agents in the treatment of ischemic cardiovascular states. We review what is presently known about the use of nitrates and nitrites including the historical, current, and potential uses of these agents, and their mechanisms of action.

摘要

有机亚硝酸盐,即亚硝酸戊酯,最初被用作心绞痛的治疗药物,但在十多年后,因其给药方便且作用持续时间更长,被有机硝酸盐,即硝酸甘油(NTG)所取代。自现代药理学诞生以来,硝酸酯类药物,如 NTG,一直被用于心绞痛和心力衰竭的治疗。它们的临床疗效是由于其在大静脉和动脉中的血管扩张活性,而这种活性的作用机制目前尚未确定,可能是通过释放一氧化氮(NO)或类似 NO 的化合物来实现的。主要的缺点是 NTG 会产生耐受性,而亚硝酸戊酯的作用持续时间和给药途径也存在问题。尽管亚硝酸盐已不再用于治疗高血压或缺血性心脏病,但最近发现亚硝酸盐阴离子具有新的药理作用,如调节缺氧性血管扩张和在缺血再灌注损伤中提供细胞保护作用。尽管这两类(亚硝酸盐和有机硝酸盐)化学物质的作用经常被认为相似,但我们仍然不了解它们的作用机制。最后,亚硝酸盐阴离子(无论是来自亚硝酸钠还是中间的 NTG 形式)可能作为 NO 的储存形式,并为研究这些药物在治疗缺血性心血管疾病中的应用提供支持。我们回顾了硝酸盐和亚硝酸盐的用途,包括这些药物的历史、当前和潜在用途,以及它们的作用机制。